ARELO - Company finances
|
EUR
|
2023
From: 2023-08-22
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | 0 | 9,431 | 24,467 |
| Profit before tax | 0 | -12,276 | 1,803 |
| Net profit | 0 | -12,276 | 1,803 |
| Equity | 1 | 14,925 | 31,349 |
| Liabilities | 0 | 72 | 845 |
| Non-current assets | 0 | 0 | 0 |
| Current assets | 1 | 14,997 | 32,194 |
| Total assets | 1 | 14,997 | 32,194 |
|
Taxes paid
|
|||
| STI taxes | - | 530 | 544 |
|
Financial indicators
|
|||
| Revenue change y/y | - | - | +159.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.0% | -81.9% | 5.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.0% | -82.3% | 5.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | -130.2% | 7.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | -130.2% | 7.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | 12,234 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
ARELO - Social security debts
The company had no debts to Sodra
ARELO - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-06-24 | 2025-06-25 | 1.92 |
| 2025-06-19 | 2025-06-23 | 451.92 |
| 2025-06-12 | 2025-06-18 | 450.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
ARELO, MB (code 306326326) is a Small partnership engaged in the retail sale of pharmaceutical products. In 2025, the company generated revenue of €24.5K, up from €9.4K in 2024, which indicates strong year-on-year growth of 159.4%. Profitability also improved materially: net profit reached €1.8K in 2025 after a net loss of €12.3K in 2024. The 2025 profit margin was 7.4%, compared with a negative margin in the prior year. The balance sheet strengthened over the period, with total assets increasing to €32.2K and equity rising to €31.3K. Liabilities remained low at €845, resulting in an equity ratio of 97.4% and a debt-to-equity ratio of 0.03. Return on equity stood at 5.8% and return on assets at 5.6% in 2025. Asset turnover was 0.76x, showing moderate use of the asset base to generate revenue. Revenue per employee was €12.2K and profit per employee was €902.